Summary
Bacterial arthritis is a bacterial infection of the joint. Apart from the classical gonococcal arthritis, nongonococcal arthritides include specific forms such as mycobacterial or Borrelia burgdorferi arthritis. Almost any bacterium can cause arthritis, provided that the route of penetration and the host response are suitable. Weakening of the host’s immune competence, pre-existing joint damage and invasive diagnostic or therapeutic procedures are the main risk factors for bacterial arthritis. Gram-positive cocci are the species most frequently involved.
The pathogenesis of bacterial damage includes release of toxins, cell production of cytokines and autoimmune reactions to specific antigens. The diagnosis can be suspected clinically but must be confirmed by culture of the synovial fluid, a test which can be complemented by scintigraphy. Amplification of bacterial DNA by polymerase chain reaction is a new procedure that could become an important tool for quick diagnosis.
Treatment is based on joint drainage and antibiotics, which should be started as soon as the diagnosis is suspected. Corollary strategies under investigation include corticosteroids to prevent joint damage, monoclonal antibodies to arthritogenic peptides of bacteria or to surface markers of host lymphocytes, and modulators of synovial fluid cytokines.
Similar content being viewed by others
References
Goldenberg DL. Bacterial arthritis. In: Kelley WN, Harris ED, Ruddy S, et al., editors. Textbook of rheumatology. Philadelphia: Saunders, 1993: 1449–66
Meyer JL, Hoffman GS. Mycobacterial and fungal infections. In: Kelley WN, Harris ED, Ruddy S, et al., editors. Textbook of rheumatology. Philadelphia: Saunders, 1993: 1467–83
Schnitzer TJ. Viral arthritis. In: Kelley WN, Harris ED, Ruddy S, et al., editors. Textbook of rheumatology. Philadelphia: Saunders, 1993: 1494–508
Huppertz H, Niki NPH, Chantler JK. Susceptibility of normal human joint tissue to viruses. J Rheumatol 1991; 18: 699–704
Cimmino MA, Picciotto A, Sinelli N, et al. Has hepatitis C virus a specific tropism for the synovial membrane? Br J Rheumatol. In press
Feng L, Bulbul R, Schumacher RH, et al. Molecular detection of bacterial DNA in venereal-associated arthritis. Arthritis Rheum 1996; 39: 950–8
Granfors K, Jalkanen S, von Essen R, et al. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl JMed 1989; 320: 216–21
Snydman DR, Schenken DP, Berardi VP, et al. Borrelia burgdorferi in joint fluid in chronic Lyme arthritis. Ann Intern Med 1986; 104:798–800
Weyand CM, Goronzy JJ. Immune responses to Borrelia burgdorferi in patients with reactive arthritis. Arthritis Rheum 1989; 32: 1057–64
Scofield RH, Warren WL, Koelsch G, et al. A hypothesis for the immune dysregulation in spondyloarthropathy: contributions from enteric organisms, B27 structure, peptides bound by B27 and convergent evolution. Proc Natl Acad Sci USA 1993; 90: 9330–4
Ho Jr G. Bacterial arthritis. Curr Opin Rheumatol 1992; 4: 509–15
Goldenberg DL. Bacterial arthritis. Curr Opin Rheumatol 1994; 6: 394–400
Goldenberg DL. Bacterial arthritis. Curr Opin Rheumatol 1995; 7: 310–4
Hedström SA. Septic bone and joint infections. Curr Opin Rheumatol 1996; 8: 322–6
Patti JM, Bremell T, Krajewska-Pietrasik D, et al. The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect Immun 1994; 62: 152–61
Saez-Llorens X, Mustafa MM, Ramilo O, et al. Tumor necrosis factor a and interleukin 1β in synovial fluid of infants and children with suppurative arthritis. Am J Dis Child 1990; 144: 353–6
Saez-Llorens X, Jafari HS, Olsen KD, et al. Induction of suppurative arthritis in rabbits by Haemophilus endotoxin, tumor necrosis factor-alpha, and interleukin-1 beta. J Infect Dis 1991; 163: 1267–72
Cunningham R, Cockayne A, Humphreys H. Clinical and molecular aspects of the pathogenesis of Staphylococcus aureus bone and joint infections. J Med Microbiol 1996; 44: 157–64
Bremell T, Tarkowski A. Preferential induction of septic arthritis and mortality by superantigen-producing staphylococci. Infect Immun 1995; 63: 4185–7
Zhao YX, Abdelnour A, Holmdahl R, et al. Mice with the xid B cell defect are less susceptible to developing staphylococcus aureus-induced arthritis. J Immunol 1995; 155: 2067–76
Goldenberg DL, Reed JI. Bacterial arthritis. N Engl J Med 1985; 312: 764–71
Petersen BH, Lee TJ, Snyderman R, et al. Neisseria meningitidis and Neisseria gonorrhoeae bacteremia associated with C6, C7 or C8 deficiency. Ann Intern Med 1979; 90: 917–20
Goldenberg DL. Infectious arthritis complicating rheumatoid arthritis and other chronic rheumatic disorders. Arthritis Rheum 1989; 32: 496–502
Went P, Krismer M, Frischhut B. Recurrence of infection after revision of infected hip arthroplasties. J Bone Joint Surg Br 1995; 77: 307–9
Gray RG, Gottlieb NL. Intra-articular corticosteroids: an updated assessment. Clin Orthop Rel Res 1983; 177: 235–63
Östennson A, Geborek P. Septic arthritis as non-surgical complication in rheumatoid arthritis: relation to disease activity and therapy. Br J Rheumatol 1991; 30: 35–8
Armstrong RW, Bolding F. Septic arthritis after arthroscopy: the contributing roles of intraarticular steroids and environmental factors. Am J Infect Control 1994; 22: 16–8
Dubost JJ, Fis I, Denis P, et al. Polyarticular septic arthritis. Medicine 1993; 72: 296–310
Pfister HW, Wilske B, Weber K. Lyme borreliosis: basic science and clinical aspects. Lancet 1994; 343: 1013–6
Stanek G, O’Connell S, Cimmino MA, et al. European Union concerted action on risk assessment in Lyme borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 1996; 108: 741–7
Haupl T, Hahn G, Rittig M, et al. Persistence of Borrelia burgdorferi in ligamentous tissue from a patient with chronic Lyme borreliosis. Arthritis Rheum 1993; 36: 1621–6
Steere AC, Schoen RT, Taylor E. The clinical evolution of Lyme arthritis. Ann Int Med 1987; 107: 725–31
Shmerling RH, Delbanco TL, Tosteson ANA, et al. Synovial fluid tests: what should be ordered? JAMA 1991; 264: 1009–14
Singleton JD, West SG, Nordstrom DM. Pseudoseptic arthritis complicating rheumatoid arthritis: a report of six cases. J Rheumatol 1991; 18: 1319–22
McCarty DJ. Synovial fluid. In: McCarty DJ, editor. Arthritis and allied conditions. Philadelphia: Lea and Febiger, 1979; 51–69
Kortekangas P, Aro HT. Synovial fluid leukocytosis in bacterial arthritis vs reactive arthritis and rheumatoid arthritis in the adult knee. Scand J Rheumatol 1992; 21: 283–8
Gratacos J, Vila J, Moya F, et al. D-lactic acid in synovial fluid: a rapid diagnostic test for bacterial arthritis. J Rheumatol 1995; 22: 1504–8
Cimmino MA, Tobia F, Pesce CM, et al. Alkaline phosphatase activity of the synovial fluid and membrane. In: Hämäläinen M, Hagena FW, Schwägerl W, et al., editors. Revisional surgery in rheumatoid arthritis. Basel: Karger, 1990; 172–85
Borenstein DG, Gibbs CA, Jacobs RP. Gas-liquid Chromatographic analysis of synovial fluid. Arthritis Rheum 1982; 25: 947–53
Dory MA, Wautelet MJ. Arthroscopy in septic arthritis. Arthritis Rheum 1985; 28: 198–203
Liebling MR, Arkfeld DG, Michelini GA, et al. Identification of Neisseria gonorrhoeae in synovial fluid using the polymerase chain reaction. Arthritis Rheum 1994; 37: 702–9
Lim-Dunham JE, Ben-Ami TE, Yousefzadeh DK, et al. Septic arthritis of the elbow in children: the role of sonography. Pediatr Radiol 1995; 25: 556–9
Sandrasegaran K, Saifuddin A, Coral A, et al. Magnetic resonance imaging of septic sacroiliitis. Skeletal Radiol 1994; 23: 289–92
Sundberg SB, Savage JP, Foster BK. Technetium phosphate bone scan in the diagnosis of septic arthritis in childhood. J Pediatr Orthop 1989; 9: 579–83
Flivik G, Sloth M, Rydholm U, et al. Technetium-99mnanocolloid scintigraphy in orthopedic infections: a comparison with indium-111-labeled leukocytes. J Nucl Med 1993; 34: 1646–50
Ooi GC, Belton I, Finlay D. Comparison of technetium 99m nanocolloid and indium 111 leucocytes in the diagnosis of orthopedic infections. Br J Radiol 1993; 66: 1025–30
Mudun A, Unal S, Aktay R, et al. Tc-99m nanocolloid and Tc-99m MDP three-phase bone imaging in osteomyelitis and septic arthritis: a comparative study. Clin Nucl Med 1995; 20: 772–8
Barrow SA, Graham W, Jyawook S, et al. Localization of indium-111-immunoglobulin G, technetium 99m immunogiobulin G and indium-111-labeled white blood cells at sites of acute bacterial infection in rabbits. J Nucl Med 1993; 34: 1975–9
Thomas PA, Mullan B. Avidin indium 111-labeled WBC accumulation in a patient with active osteoarthritis of both knees. Clin Nucl Med 1995; 20: 973–5
Ho Jr G. How best to drain an infected joint: will we ever know for certain? J Rheumatol 1993; 20: 2001–3
Jackson RW. The minimally invasive treatment of septic arthritis [editorial]. J Rheumatol 1993; 20: 2004
Ike RW. Tidal irrigation in septic arthritis of the knee: a potential alternative to surgical drainage. J Rheumatol 1993; 20: 2104–11
Chung WK, Slater GL, Bates EH. Treatment of septic arthritis of the hip by arthroscopic lavage. J Pediatr Orthop 1993; 13: 444–6
Nord KD, Dore DD, Deeney VF, et al. Evaluation of treatment modalities for septic arthritis with histological grading and analysis of levels of uronic acid, neutral protease, and interleukin-1. J Bone Joint Surg Am 1995; 77: 258–65
Fung MF, Louie JS. Infectious agent arthritis. In: Weisman MH, Weinblatt ME, editors. Treatment of the rheumatic diseases. Philadelphia: Saunders, 1995: 321–4
Tissi L, von Hunolstein C, Mosci P, et al. In vivo efficacy of azithromycin in treatment of systemic infection and septic arthritis induced by type IV group B streptococcus strain in mice: comparative study with erythromycin and penicillin G. Antimicrob Agents Chemother 1995; 39: 1938–47
Schurman DJ, Kajiyama G. Antibiotic absorption from infected and normal joints using a rabbit knee model. J Orthop Res 1985; 3: 185–9
Orchard RA, Stamp WG. Early treatment of induced suppurative arthritis in rabbit knee joints. Clin Orthop 1968; 59: 287–91
Jafari HS, Saez-Llorens X, Paris M, et al. Dexamethasone attenuation of cytokine-mediated articular cartilage degradation in experimental lapine haemophilus arthritis. J Infect Dis 1993; 168: 1186–93
Wysenbeek AJ, Leitman M, Amit M, et al. Experimental septic arthritis in rabbits treated by a combination of antibiotic and steroid drugs. Clin Exp Rheumatol 1996; 14: 507–12
Ricci ML, von Hunolstein C, Gomez MJ, et al. Protective activity of a murine monoclonal antibody against acute and chronic experimental infection with type IV group B streptococcus. J Med Microbiol 1996; 44: 475–81
Cimmino MA, Moggiana GL, Parisi M, et al. Treatment of Lyme arthritis. Infection 1996; 24: 91–4
Cimmino MA, Accardo S. Long term treatment of chronic Lyme arthritis with benzathine penicillin. Ann Rheum Dis 1992; 51: 1007–8
Schoen RT, Aversa JM, Rahn DW, et al. Treatment of refractory chronic Lyme arthritis with arthroscopic synovectomy. Arthritis Rheum 1991; 34: 1056–60
Cole AA, Chubinskaya S, Luchene LJ, et al. Doxycycline disrupts chondrocyte differentiation and inhibits cartilage matrix degradation. Arthritis Rheum 1994; 37: 1727–34
Lidwell OM, Elson RA, Lowbury EJ, et al. Ultraclean air and antibiotics for the prevention of postoperative infection: a multicenter study of 8052 joint replacement operations. Acta Orthop Scand 1987; 58: 4–12
Peters RHJ, Rasker JJ, Jacobs JWG, et al. Bacterial arthritis in a district hospital. Clin Rheumatol 1992; 152: 351–5
Esterhai Jr JL, Gelb I. Adult septic arthritis. Orthop Clin North Am 1991; 22: 503–14
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cimmino, M.A. Recognition and Management of Bacterial Arthritis. Drugs 54, 50–60 (1997). https://doi.org/10.2165/00003495-199754010-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199754010-00004